DRDB: A Machine Learning Platform to Predict Chemical-Protein Interactions towards Diabetic Retinopathy.

导出 OA

翻译打印收藏纠错

作者： Yu,Wei ^[1] ; Ruili,Zhang ^[1] ; Xiaoqiang,Li ^[2] ; Zhonglin,Li ^[1] ; Kaimin,Guo ^[2] ; Shanshan,Li ^[1] ; Li,Yan ^[1] ; Qian,Zhao ^[2] ; Baijian,Qu ^[1] ; Wenjia,Wang ^[2] ; Shuiping,Zhou ^[3] ; He,Sun ^[2] ; Jianping,Lin ^[3] ; Yunhui,Hu ^[1]

作者单位： State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Responses, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China. ^[1] Cloudphar Pharmaceuticals Co., Ltd., Shenzhen, China. ^[2] The State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Academy, Tasly Holding Group Co., Ltd., No. 1, Tingjiang West Road, Beichen District, Tianjin 300410, China. ^[3]

主题词算法(Algorithms);糖尿病(Diabetes Mellitus);糖尿病视网膜病变(Diabetic Retinopathy);人类(Humans);蛋白质类(Proteins);量化构效关系(Quantitative Structure-Activity Relationship)

DOI 10.1155/2022/1718353

PMID 35910835

发布时间 2022-08-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Oxidative medicine and cellular longevity

2022年2022卷

1718353页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

DRDB: A Machine Learning Platform to Predict Chemical-Protein Interactions towards Diabetic Retinopathy.

Oxidative medicine and cellular longevity

相似文献

Oxidative medicine and cellular longevity

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

DRDB: A Machine Learning Platform to Predict Chemical-Protein Interactions towards Diabetic Retinopathy.

Oxidative medicine and cellular longevity

相似文献

Oxidative medicine and cellular longevity

相关期刊

检索历史清除